<DOC>
	<DOCNO>NCT00859716</DOCNO>
	<brief_summary>The purpose study determine whether ACE393 vaccination protect Campylobacteriosis challenge model .</brief_summary>
	<brief_title>ACE393-103 Vaccination Challenge Study</brief_title>
	<detailed_description>This study randomize , double blind , parallel group , placebo control study , subject , evidence prior C.jejuni infection immunity , vaccinate ACE393 , protein sub-unit vaccine , placebo , subsequently challenge C.jejuni . The study include vaccination approximately 72 subject , aim challenge total 60 subject . ACE393 placebo administer twice intramuscular injection outpatient basis , three week apart subject challenge three week later C.jejuni . During inpatient monitoring period , volunteer evaluate daily safety , clinical sign symptom disease stool microbiology ) . Criteria early institution oral hydration , intravenous fluid , serum electrolyte monitoring , blood culture , and/or antibiotic predefined . All volunteer receive antibiotic therapy 6 day challenge ( unless treat early ) . Discharge criterion predefined . Post-discharge follow-up monitor safety , confirm C .jejuni eradication antibiotic therapy , assess immunologic response .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Campylobacter Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion ( select ) : Male female 18 50 year age . General good health , without significant medical illness , abnormal physical examination finding clinical laboratory abnormality determine principal investigator principal investigator consultation medical monitor sponsor . Negative serum pregnancy test screening . Exclusion Criteria ( select ) : Immunosuppressive illness clinically significant IgA deficiency . Positive serology result HIV , HBsAg , HCV antibody . Evidence inflammatory arthritis examination and/or HLAB27 positive . Allergy prior intolerance select antibiotic ( specify protocol ) Fewer 3 stool per week 3 stool per day usual frequency ; pass loose liquid stool occasional basis . History diarrhea . Stool culture positive Campylobacter , bacterial enteropathogens intestinal parasite . History microbiologically confirm Campylobacter infection . History vaccination ingestion Campylobacter . Immunologic evidence Campylobacter exposure Serologic evidence prior Campylobacter infection . Cell mediate immune response evidence prior Campylobacter infection . Fever within 48 hour precede challenge . Presence sign symptom indicative active infection . Diarrhea occur 7 day prior challenge . Stool culture positive Campylobacter , bacterial enteric pathogen intestinal parasite .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Vaccination</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Traveler 's Diarrhea</keyword>
	<keyword>Campylobacter jejuni</keyword>
	<keyword>C. jejuni</keyword>
	<keyword>Campylobacter</keyword>
	<keyword>Campy</keyword>
</DOC>